Filter
1661
Text search:
pharmaceutical
services
Featured
154
428
Language
Document type
813
343
255
91
87
22
19
12
9
5
4
1
Countries / Regions
76
71
70
63
49
43
37
37
32
31
26
26
25
24
23
22
22
20
20
19
18
18
16
15
14
14
12
12
12
11
9
9
9
8
7
6
6
6
5
5
5
5
5
5
5
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
728
99
80
72
38
26
14
2
Toolboxes
164
148
128
99
77
65
52
36
35
34
32
32
28
26
21
20
13
12
11
9
8
7
4
3
1
Guideline ‒ Alternative mass drug administration regimens to eliminate lymphatic filariasis
recommended
Lymphatic filariasis is a vector-borne neglected tropical disease that causes damage of the lymphatic system and can lead to lymphoedema (elephantiasis) and hydrocele in infected individuals. The global baseline estimate of persons affected by lymphatic filariasis is 25 million men with hydrocele an
...
These guidelines present evidence-based recommendations and best practice statements on use of medically important antimicrobials in food-producing animals, based on the WHO list of critically important antimicrobials for human medicine (WHO CIA List). These guidelines aim primarily to help preserve
...
Application of a One Health approach .
The present guidance was developed with the support of the WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR) to assist countries and other stakeholders in the establishment and development of programmes of integrated surveillan
...
Made under Section 5 (c) of the Tanzania Food, Drugs and Cosmetics Act, 2003 | Second Edition
Lessons from the STEP-TB Project.
Accessed November 2017.
A review of available evidence (2016).
28-29 June 2016; Geneva, Switzerland
The END TB strategy.
International Journal of Infectious Diseases 32 (2015) 111–117
Mapping Report - Catalonia (Spain).
